These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 16202986

  • 1. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model.
    Ikeda Y, Hokamura K, Kawai T, Ishiyama J, Ishikawa K, Anraku T, Uno T, Umemura K.
    Brain Res; 2005 Oct 26; 1060(1-2):73-80. PubMed ID: 16202986
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabó C, Endres M.
    Int J Mol Med; 2001 Mar 26; 7(3):255-60. PubMed ID: 11179503
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.
    Egi Y, Matsuura S, Maruyama T, Fujio M, Yuki S, Akira T.
    Brain Res; 2011 May 10; 1389():169-76. PubMed ID: 21420942
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG, Thiyagarajan M, Kaul CL, Sharma SS.
    Brain Res Bull; 2004 Feb 01; 62(5):425-33. PubMed ID: 15168908
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats.
    Takahashi K, Greenberg JH, Jackson P, Maclin K, Zhang J.
    J Cereb Blood Flow Metab; 1997 Nov 01; 17(11):1137-42. PubMed ID: 9390644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia.
    Chiarugi A, Meli E, Calvani M, Picca R, Baronti R, Camaioni E, Costantino G, Marinozzi M, Pellegrini-Giampietro DE, Pellicciari R, Moroni F.
    J Pharmacol Exp Ther; 2003 Jun 01; 305(3):943-9. PubMed ID: 12606624
    [Abstract] [Full Text] [Related]

  • 13. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors.
    Giovannelli L, Cozzi A, Guarnieri I, Dolara P, Moroni F.
    J Cereb Blood Flow Metab; 2002 Jun 01; 22(6):697-704. PubMed ID: 12045668
    [Abstract] [Full Text] [Related]

  • 14. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.
    Lenzsér G, Kis B, Snipes JA, Gáspár T, Sándor P, Komjáti K, Szabó C, Busija DW.
    J Cereb Blood Flow Metab; 2007 Jul 01; 27(7):1318-26. PubMed ID: 17213862
    [Abstract] [Full Text] [Related]

  • 15. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
    Yi JS, Kim YH, Koh JY.
    Exp Neurol; 2004 Oct 01; 189(2):354-60. PubMed ID: 15380485
    [Abstract] [Full Text] [Related]

  • 16. Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit?
    Yap E, Tan WL, Ng I, Ng YK.
    Brain Res; 2008 Feb 21; 1195():130-8. PubMed ID: 18207135
    [Abstract] [Full Text] [Related]

  • 17. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
    Mey L, Hörmann M, Schleicher N, Reuter P, Dönges S, Kinscherf R, Gassmann M, Gerriets T, Al-Fakhri N.
    Neurobiol Dis; 2013 Nov 21; 59():111-25. PubMed ID: 23816753
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N, Sharma G, Singh N, Hanif K.
    Int J Stroke; 2014 Jul 21; 9(5):560-8. PubMed ID: 23013350
    [Abstract] [Full Text] [Related]

  • 20. Poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide rescues N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats through preservation of nuclear factor-kappaB activity.
    Miki K, Uehara N, Shikata N, Matsumura M, Tsubura A.
    Exp Eye Res; 2007 Feb 21; 84(2):285-92. PubMed ID: 17137578
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.